Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) rose 11.1% during trading on Tuesday . The company traded as high as GBX 3.68 and last traded at GBX 3.50. Approximately 20,624,805 shares were traded during mid-day trading, an increase of 1,413% from the average session volume of 1,363,058 shares. The stock had previously closed at GBX 3.15.
Cizzle Biotechnology Trading Up 3.4%
The company has a market capitalization of £12.75 million, a price-to-earnings ratio of -17.65 and a beta of 0.02. The business’s 50 day moving average price is GBX 2.75 and its two-hundred day moving average price is GBX 2.03.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
